Pneumococcal hemolytic uremic syndrome and steroid resistant nephrotic syndrome
- PMID: 27478599
- PMCID: PMC4957713
- DOI: 10.1093/ckj/sfw025
Pneumococcal hemolytic uremic syndrome and steroid resistant nephrotic syndrome
Abstract
Pneumococcal-associated hemolytic uremic syndrome (pHUS) is a rare but severe complication of invasive Streptococcus pneumoniae infection. We report the case of a 12-year-old female with steroid-resistant nephrotic syndrome treated with adrenocorticotrophic hormone (H.P. Acthar(®) Gel), who developed pneumococcal pneumonia and subsequent pHUS. While nephrotic syndrome is a well-known risk factor for invasive pneumococcal disease, this is the first reported case of pHUS in an adolescent patient with nephrotic syndrome, and reveals novel challenges in the diagnosis, treatment and potential prevention of this complication.
Keywords: Acthar; hemolytic; nephrotic; streptococcus; uremic.
Figures
References
-
- Banerjee R, Hersh AL, Newland J et al. . Streptococcus pneumoniae-associated hemolytic uremic syndrome among children in North America. Pediatr Infect Dis J 2011; 30: 736–739 - PubMed
-
- Klein PJ, Bulla M, Newman RA et al. . Thomsen-Friedenreich antigen in haemolytic-uraemic syndrome. Lancet 1977; 2: 1024–1025 - PubMed
-
- Cochran JB, Panzarino VM, Maes LY et al. . Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome and anemia. Pediatr Nephrol 2004; 19: 317–321 - PubMed
-
- McGraw ME, Lendon M, Stevens RF et al. . Haemolytic uraemic syndrome and the Thomsen Friedenreich antigen. Pediatr Nephrol 1989; 3: 135–139 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
